Switzerland: US FDA’s Medtech Can Bridge Innovation Gap Left By MDR
Medtech industry wants more urgency from Swiss authorities to address worsening product shortfall
Setting the patient safety bar too high will likely have the opposite effect in the case of the EU MDR. So believes the medtech industry in Switzerland, where work has begun at government level to pave the way for Swiss patients to have access to US FDA-approved medtech.
